Healthcare provider profile · identity verified

Stacey A. Nakano, MD

Family Practice · SACRAMENTO, CA · NPI 1073691739

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Amlodipine Besylate	Amlodipine Besylate	494	166
Levothyroxine Sodium	Levothyroxine Sodium	402	121
Atorvastatin Calcium	Atorvastatin Calcium	399	140
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	242	56
Lisinopril	Lisinopril	216	76
Albuterol Sulfate Hfa	Albuterol Sulfate	212	101
Alvesco	Ciclesonide	153	68
Atenolol	Atenolol	153	47
Famotidine	Famotidine	149	65
Losartan Potassium	Losartan Potassium	143	50
Gabapentin	Gabapentin	132	51
Fluticasone Propionate	Fluticasone Propionate	128	52
Simvastatin	Simvastatin	128	40
Ibuprofen	Ibuprofen	123	56
Alendronate Sodium	Alendronate Sodium	111	40
Metoprolol Succinate	Metoprolol Succinate	111	42
Duloxetine Hcl	Duloxetine Hcl	110	42
Metoprolol Tartrate	Metoprolol Tartrate	101	37
Omeprazole	Omeprazole	99	45
Alprazolam	Alprazolam	96	21
Pantoprazole Sodium	Pantoprazole Sodium	96	36
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	91	31
Tizanidine Hcl	Tizanidine Hcl	87	42
Triamcinolone Acetonide	Triamcinolone Acetonide	86	36
Ozempic	Semaglutide	84	14
Cefadroxil	Cefadroxil	82	55
Trazodone Hcl	Trazodone Hcl	82	26
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	82	27
Montelukast Sodium	Montelukast Sodium	80	31
Furosemide	Furosemide	79	36
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	77	21
Hydrochlorothiazide	Hydrochlorothiazide	76	25
Sertraline Hcl	Sertraline Hcl	72	36
Spiriva Respimat	Tiotropium Bromide	70	15
Metformin Hcl Er	Metformin Hcl	69	31
Fluoxetine Hcl	Fluoxetine Hcl	66	20
Clobetasol Propionate	Clobetasol Propionate	65	32
Terazosin Hcl	Terazosin Hcl	60	16
Clopidogrel	Clopidogrel Bisulfate	58	19
Meloxicam	Meloxicam	58	24
Ondansetron Odt	Ondansetron	58	20
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	57	19
Oxycodone Hcl	Oxycodone Hcl	57	13
Pravastatin Sodium	Pravastatin Sodium	56	15
Baclofen	Baclofen	55	21
Escitalopram Oxalate	Escitalopram Oxalate	52	16
Pradaxa	Dabigatran Etexilate Mesylate	50	17
Lovastatin	Lovastatin	49	17
Eliquis	Apixaban	48	14
Mirtazapine	Mirtazapine	48	12
Prednisone	Prednisone	47	37
Metformin Hcl	Metformin Hcl	45	16
Rosuvastatin Calcium	Rosuvastatin Calcium	45	18
Allopurinol	Allopurinol	44	15
Nifedipine Er	Nifedipine	44	12
Potassium Chloride	Potassium Chloride	44	22
Hydrocortisone	Hydrocortisone	43	25
Cephalexin	Cephalexin	42	26
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	41	35
Colchicine	Colchicine	41	11
Zolpidem Tartrate	Zolpidem Tartrate	41	suppressed
Glipizide	Glipizide	40	13
Tamsulosin Hcl	Tamsulosin Hcl	40	14
Tramadol Hcl	Tramadol Hcl	39	11
Ipratropium Bromide	Ipratropium Bromide	37	12
Pregabalin	Pregabalin	37	19
Verapamil Er	Verapamil Hcl	37	15
Insulin Glargine-Yfgn	Insulin Glargine-Yfgn	36	15
Acyclovir	Acyclovir	35	18
Nystatin	Nystatin	35	21
Azithromycin	Azithromycin	34	20
Lorazepam	Lorazepam	34	14
Warfarin Sodium	Warfarin Sodium	34	suppressed
Methocarbamol	Methocarbamol	32	14
Bupropion Xl	Bupropion Hcl	27	11
Ciprofloxacin Hcl	Ciprofloxacin Hcl	27	20
Finasteride	Finasteride	26	suppressed
Humulin N	Insulin Nph Human Isophane	26	12
Memantine Hcl	Memantine Hcl	26	suppressed
Ondansetron Hcl	Ondansetron Hcl	26	13
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	24	suppressed
Propranolol Hcl	Propranolol Hcl	24	14
Spironolactone	Spironolactone	24	11
Wixela Inhub	Fluticasone Propion/Salmeterol	24	suppressed
Veo Insulin Syringe	Syringe And Needle,insulin,1ml	23	suppressed
Carvedilol	Carvedilol	22	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	22	suppressed
Humalog Kwikpen U-100	Insulin Lispro	22	suppressed
Amoxicillin	Amoxicillin	21	18
Mupirocin	Mupirocin	21	16
Adacel Tdap	Diph,pertuss(Acell),tet Vac/Pf	20	20
Doxycycline Monohydrate	Doxycycline Monohydrate	20	18
Ketoconazole	Ketoconazole	20	12
Naproxen	Naproxen	20	11
Citalopram Hbr	Citalopram Hydrobromide	19	suppressed
Estradiol	Estradiol	19	11
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	19	18
Cyclosporine	Cyclosporine	18	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	18	suppressed
Metronidazole	Metronidazole	18	suppressed
Lidocaine-Prilocaine	Lidocaine/Prilocaine	17	suppressed
Ropinirole Hcl	Ropinirole Hcl	17	suppressed
Celecoxib	Celecoxib	16	suppressed
Clonidine Hcl	Clonidine Hcl	16	suppressed
Humulin R	Insulin Regular, Human	16	suppressed
Jardiance	Empagliflozin	16	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	16	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	16	suppressed
Veo Insulin Syringe	Syringe-Needle,insulin,0.5 Ml	16	suppressed
Xarelto	Rivaroxaban	16	suppressed
Paroxetine Hcl	Paroxetine Hcl	15	suppressed
Cefpodoxime Proxetil	Cefpodoxime Proxetil	14	suppressed
Digoxin	Digoxin	14	suppressed
Fluconazole	Fluconazole	14	suppressed
Hydralazine Hcl	Hydralazine Hcl	14	suppressed
Retin-A	Tretinoin	14	suppressed
Asmanex Hfa	Mometasone Furoate	13	suppressed
Donepezil Hcl	Donepezil Hcl	13	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	13	suppressed
Acetic Acid	Acetic Acid	12	suppressed
Levofloxacin	Levofloxacin	12	suppressed
Nabumetone	Nabumetone	12	suppressed
Phenytoin Sodium Extended	Phenytoin Sodium Extended	12	suppressed
Topiramate	Topiramate	12	suppressed
Combivent Respimat	Ipratropium/Albuterol Sulfate	11	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	11	suppressed
Lamotrigine	Lamotrigine	11	suppressed
Lidocaine	Lidocaine	11	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	11	suppressed
Serevent Diskus	Salmeterol Xinafoate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error